Original Research
Accepted on 25 Jun 2025
Evaluation of PhenoMATRIX® PLUS for the culture-based rectal screening of CPOs, ESBL-E, Acinetobacter, and VRE carriage
in Antimicrobials, Resistance and Chemotherapy
- 118 views
Original Research
Accepted on 25 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 25 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 25 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 25 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 25 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 24 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 24 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 24 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 23 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 20 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 20 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Perspective
Published on 20 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 19 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 19 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Editorial
Published on 19 Jun 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 18 Jun 2025
in Antimicrobials, Resistance and Chemotherapy